Semaglutide
Ozempic, Rybelsus, Wegovy
A long-acting GLP-1 receptor agonist used for type 2 diabetes and obesity management by enhancing insulin secretion and suppressing appetite.
Active Not Recruiting
PHASE3
NCT04822181
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT06507475
Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes
Novo Nordisk A/S
OBSERVATIONAL
Updated Dec 15, 2025
Not Yet Recruiting
PHASE2
NCT07187856
Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus
ProGen. Co., Ltd.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT05813912
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT05920889
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
Chinese University of Hong Kong
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT03724981
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Eli Lilly and Company
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT05779644
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
RenJi Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NCT06686134
Comprehensive Clinical Evaluation Study of GLP-1RA
LI YAN
OBSERVATIONAL
Updated Dec 15, 2025
Recruiting
EARLY PHASE1
NCT06338553
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Vanderbilt University Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT05153564
A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT05478252
A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT05442450
Efficacy of Oral Semaglutide in Overweight or Obesity
Asian Institute of Gastroenterology, India
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NCT04972721
SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
Novo Nordisk A/S
OBSERVATIONAL
Updated Dec 15, 2025
Not Yet Recruiting
NA
NCT06836284
The Evira Study: Additional Support During Anti-Obesity Treatment
Karolinska Institutet
INTERVENTIONAL
Updated Dec 15, 2025
Not Yet Recruiting
PHASE2
NCT07221214
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Vanderbilt University Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT05606471
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
University of Nottingham
INTERVENTIONAL
Updated Dec 15, 2025
Withdrawn
PHASE3
NCT04885634
Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
Axel Brandes
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04788511
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE4
NCT06396416
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Western University, Canada
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04998136
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025